Analyst Thomas McCrann Merrill Lynch reiterate "buy" recommendation Wang Laboratories Inc note successful cost cut campaign reduce earnings loss expect third quarter end March. Wang actively trade stock American Stock Exchange rise 3/4 16-5/8. McCrann "Wang little bit ahead expect cost reduction result odds increase loss quarter expected." McCrann expect Wang report break earnings share loss share third quarter. He company report loss 50 ct share compare earnings 35 ct share ago. Reuter 